English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduScientists at St. Jude Children’s Research Hospital identified a panel of 27 proteins that could accurately predict treatment-related cardiomyopathy risk among childhood cancer survivors.
Tag: Cancer
Enzyme identified as new therapeutic target for “cold” tumors
A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy resistance.
More Cancers Are Being Treated with Personalized Therapies Before Surgery
The first-ever annual report from the American College of Surgeons National Cancer Database includes in-depth data on adult cancer diagnoses and treatment trends.
A Cause of Hyperinflammatory Response in Lethal COVID-19 Identified
As part of the COVID-19 International Research Team, researchers at the Johns Hopkins Kimmel Cancer Center, Children’s Hospital of Philadelphia, the University of Pittsburgh and Weill Cornell Medicine discovered a novel cause of cytokine storm — the extreme inflammatory response associated with increased risk of death in COVID-19 infection.
Unexpected findings in study of T cells considered front-line fighters against advanced melanoma
Yale researchers made an unexpected discovery—turncoat T cells that help a tumor evade other cancer-fighting immune T cells—in a study of patients living with advanced melanoma that was published Nov. 28 in Nature Immunology.
Rutgers Cancer Institute and RWJBarnabas Health to Unveil Pioneering Blood Cancer Research at the 66th American Society of Hematology Annual Meeting and Exposition
Physician-scientists from Rutgers Cancer Institute and RWJBarnabas Health will showcase a diverse range of hematology/oncology data from their clinical research program at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held in San Diego, California (and online) from December 7-10, 2024.
Sunflower Bank Brings Back Beloved Model Train Display for the Holidays, Supporting Lighting Campus for Hope
New this year, the holiday display in Sunflower Bank’s Downtown lobby, 201 E. Main, Suite 200, includes lavender ribbons to support our community’s cancer warriors. These ribbons represent awareness and solidarity for all who have shown strength in their fight against any form of cancer.
UM researchers using AI to improve cancer research and early detection of genetic diseases
UM researchers recently developed a new genomics method with the potential to reveal the genetic mechanisms behind human health and disease. The recent publication in the journal Genome Biology offers an innovative new pathway to study the root causes of diseases like cancer and dementia to someday allow for early detection.
Schlechter named Cancer Moonshot Scholar
Chelsey Schlechter, PhD, MPH, has been chosen as a Cancer Moonshot Scholar. She is one of eleven researchers from across the country who have been selected for the prestigious honor.
Exosome-based strategy against colon cancer using small interfering RNA-loaded vesicles targeting soluble a proliferation-inducing ligand
BACKGROUNDRecent advancements in nanomedicine have highlighted the potential of exosome (Ex)-based therapies, utilizing naturally derived nanoparticles, as a novel approach to targeted cancer treatment. AIMTo explore the targetability and
Moffitt Study Shows How Cancer Cell Death May Harm the Immune System and Promote Tumor Growth
A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell death can actually make tumors grow faster by turning off the immune system’s ability to fight the cancer.
Advancing Breast Cancer Research: Yale Cancer Center to Share Insights at International Conference
Yale Cancer Center (YCC) researchers at Yale School of Medicine will present new research at the 47th annual San Antonio Breast Cancer Symposium (SABCS) at the Henry B. Gonzalez Convention Center from December 10 to 13.
UT Southwestern brings first-of-its-kind radiation oncology to new $177M campus in Fort Worth Medical District
To meet the growing demands for cancer treatment in Tarrant County and surrounding areas, UT Southwestern Medical Center is expanding its cancer services in the Fort Worth Medical District with construction of a new two-story Radiation Oncology campus that will house the city’s first MRI-guided precision radiation treatment.
How race impacts patients’ response to cancer immunotherapy
Clinical trials testing cancer immunotherapies significantly under-represented Black patients. So while these treatments have resulted in dramatically improved outcomes for some patients, researchers from the University of Michigan Rogel Cancer Center wanted to understand whether that success holds true for patients who are Black.
ASTRO issues update to clinical guideline on radiation therapy for rectal cancer
The American Society for Radiation Oncology (ASTRO) issued today an updated clinical guideline for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. This update incorporates new data on patient selection and best practices from several practice-changing clinical trials published since the prior guideline was issued in 2020.
Psychological therapy offers new hope for young Latino testicular cancer survivors
Pilot intervention looks at ways to bridge gaps in survivorship care, empowering young Latino men to manage distress and reclaim meaningful life goals after cancer treatment.
How ecDNA Fuels Cancer by Breaking the Laws of Biology
How ecDNA Fuels Cancer by Breaking the Laws of Biology
November Research Tip Sheet
Cedars-Sinai has published a summary highlighting its research advances for November 2024.
International Cancer Organizations Present Collaborative Work During Oncology Event in China
The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
University of Chicago Medicine Comprehensive Cancer Center partners with Argonne National Laboratory to accelerate the discovery of new cancer therapies using AI
Researchers at the UChicago Medicine Comprehensive Cancer Center and Argonne National Laboratory are partnering to use AI approaches to discover new targets for cancer therapies
Treatment advances, predictive biomarkers stand to improve bladder cancer care
Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a New England Journal of Medicine editorial published by Matthew Milowsky, MD, FASCO, a bladder cancer expert at UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center.
“We Need Everyone”: New Award Recognizes the Importance of Scientific Community
In the lab of Minna Roh-Johnson, PhD, great science and great mentorship are inextricable. Now, up to $250,000 in federal funding from the National Cancer Institute has made that philosophy concrete by advancing cancer research and building scientific community.
MRI-guided radiation therapy reduces long-term side effects for patients with prostate cancer
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.
New study links air pollution with higher rates of head and neck cancer
A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aerodigestive cancer.
Montefiore Einstein’s Marina Konopleva Joins Break Through Cancer TeamLab in Fight Against Acute Myelogenous Leukemia
Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.
Data detectives strike back at deadly childhood cancer
Neuroblastoma is a rare and aggressive form of childhood cancer. Striking in infancy, it shatters what should be a family’s time of joy, shifting it to a fight for survival. While the search for a cure continues, researchers at the University of South Australia are striving to decode the causes of neuroblastoma to inform new, less toxic treatment strategies for young patients.
أوصى باحثو مايو كلينك ببدائل لاستئصال الرحم لعلاج الأورام الليفية في الرحم، وفقًا لدراسة
روتشستر، مينيسوتا — تُعد الأورام الليفية الرحمية حالة شائعة تؤثر على ما يصل إلى 80٪ من النساء خلال حياتهن. سيعاني ما يقرب من نصف هؤلاء النساء من أعراض تؤثر على جودة حياتهن وقدرتهن على الإنجاب، بما في ذلك الألم الشديد وفقر الدم. تُعد الأورام الليفية الرحمية السبب الرئيسي لإجراء استئصال الرحم. ومع ذلك، يوصي باحثو مايو كلينك ببدائل علاجية طفيفة التوغل لاستئصال الرحم، وذلك وفقًا لورقة عمل سريرية دُعيت للنشر في مجلة نيو إنجلاند الطبية.
Pesquisadores da Mayo Clinic recomendam alternativas à histerectomia para miomas uterinos, de acordo com estudo
Os miomas uterinos são uma condição comum que afeta até 80% das mulheres ao longo da vida. Quase metade dessas mulheres apresentará sintomas que afetarão sua qualidade de vida e fertilidade, incluindo dor intensa e anemia. Os miomas uterinos são a principal razão para se realizar a remoção do útero através da histerectomia. No entanto, pesquisadores da Mayo Clinic recomendam alternativas de tratamento minimamente invasivas à histerectomia em um artigo convidado sobre prática clínica publicado na New England Journal of Medicine.
Researchers make glioblastoma cells visible to attacking immune cells
Researchers at WashU Medicine have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab, forces brain cancer cells to display targets for the immune system to attack. Their study was published in Nature Genetics.
Cancer Genetic Risk Assessment Guidelines Expand to Meet Growing Understanding of Hereditary Risk
NCCN expands guidelines to create two major resources for helping cancer care providers and other stakeholders stay current on cutting edge research on genetic/familial high-risk assessment.
Detección de indicios de cáncer de pulmón en el aliento exhalado
En un estudio publicado en la revista ACS Sensors, investigadores informan del desarrollo de sensores ultrasensibles a nanoescala que, en pruebas a pequeña escala, distinguen un cambio clave en la química del aliento de personas con cáncer de pulmón.
Ancient Immune Defense System Plays an Unexpected Role in Cancer, MSK Researchers Find
Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in unexpected ways — ways that have important implications for the development of cancer, researchers at MSK are discovering.
SLU Study: Integrative Palliative Care Critical to Improve Mental Health Among Pancreatic Cancer Patients
For patients facing a pancreatic cancer diagnosis, a compassionate approach to care can be transformative. Yet, a new study published in Healthcare reveals that palliative care, a service focused on enhancing the quality of life for those with serious illnesses, remains significantly underutilized among pancreatic cancer patients in the United States.
How Hypoxia Helps Cancer Spread
Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the bloodstream after they’ve escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop cancer recurrence, and one – MUC1 – is already in clinical trials.
William K. Oh, MD, Joins Yale Cancer Center and Smilow Cancer Hospital
William K. Oh, MD, has been appointed as Medical Director of Smilow Cancer Hospital at Greenwich Hospital, as well as Director of Precision Medicine for Yale Cancer Center and Smilow Cancer Hospital.
Researchers awarded $2.5 million grant to increase lung cancer screenings in underserved communities
The funding will support a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County.
What you need to know about lung cancer
UCLA Health experts Amy Cummings, MD, PhD, and Sha’Shonda Revels, MD, address frequently asked questions about the disease.
Actor James Van Der Beek Announces Colon Cancer Diagnosis At Age 47, Part Of A Growing Trend of Young Colorectal Cancers Diagnoses
Think you’re too young for colon cancer? Think again! He was a teenage heart throb and pop icon as a young star on “Dawson’s Creek.” Now James Van Der Beek is once again an icon for people his age. The…
High levels of omega-3, omega-6 may protect against cancer
In addition to lowering your cholesterol, keeping your brain healthy and improving mental health, new research from the University of Georgia suggests omega-3 and omega-6 fatty acids may help ward off a variety of cancers. The study relied on data from more than 250,000 people and found that higher levels of omega-3 and omega-6 fatty acids were associated with a lower risk of developing cancer.
National Comprehensive Cancer Network Joins with Vietnam National Cancer Hospital to Enhance Cancer Treatment
Leaders from the National Comprehensive Cancer Network (NCCN) travel to Vietnam to collaborate with Vietnam National Cancer Hospital on improving cancer care standards throughout the country.
Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke
The ARCADIA study was a multicenter, double-blind, randomized clinical trial conducted between 2017 and 2020.
Complexity of tumors revealed in 3D
A new analysis led by researchers at Washington University School of Medicine in St. Louis has revealed detailed 3D maps of the internal structures of multiple tumor types. These cancer atlases reveal how different tumor cells — and the cells of a tumor’s surrounding environment — are organized, in 3D, and how that organization changes when a tumor spreads to other organs. The detailed findings offer scientists valuable blueprints of tumors that could lead to new approaches to therapy and spark a new era in the field of cancer biology, according to the researchers.
ACS Research Finds Lack of Health Insurance Coverage Contributes to Racial and Ethnic Disparities in Advanced-Stage Diagnosis of Multiple Cancers
A new, large study led by American Cancer Society (ACS) researchers found that lack of health insurance coverage accounts for a significant proportion of racial and ethnic disparities in advanced-stage diagnosis of multiple cancers.
NIH Director Monica M. Bertagnolli Honored with NIAF Leonardo da Vinci Award in Health and Science
The National Italian American Foundation (NIAF) presented its Leonardo da Vinci Award in Health and Science to National Institutes of Health (NIH) Director Monica M. Bertagnolli Saturday at the 49th annual NIAF gala in Washington, D.C.
Novel blood-based screening for colorectal cancer less effective, less cost-effective compared to colonoscopies or stool tests
A projected impact and cost-effectiveness analysis estimated reductions in colorectal cancer (CRC) incidence and mortality with novel blood-based and stool-based CRC screening tests versus established alternatives.
Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center.
New Advances in Prostate Cancer Diagnosis: Outcomes from the 2022 Panjiayuan Consensus Conference
The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).
UCLA efforts to provide prostate cancer treatment in the community gets $6 million boost
The UCLA Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.
Surgical innovations help personalize breast cancer treatment, improve quality of life
There are two surgical options to treat breast cancer: lumpectomy and mastectomy. But there are many more reasons why women choose one over another, says Sarah McLaughlin, M.D., a breast surgical oncologist and chair of the Department of Surgery at Mayo Clinic in Jacksonville, Florida.
Inovações cirúrgicas ajudam a personalizar o tratamento do câncer de mama e a melhorar a qualidade de vida
Existem duas opções cirúrgicas para tratar o câncer de mama: A lumpectomia e a mastectomia. Mas há muitas outras razões pelas quais as mulheres escolhem uma opção ao invés da outra, conta a Dra. Sarah McLaughlin, cirurgiã oncológica de mama e presidenta do Departamento de Cirurgia da Mayo Clinic em Jacksonville, Flórida.